 | | PRD_900102 | | Name: | methyl 3-S-alpha-D-mannopyranosyl-3-thio-alpha-D-mannopyranoside | | Formula: | C13 H24 O10 S | | Description: | oligosaccharide with S-glycosidic bond between monosaccharides | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_001133 | | Name: | (2R,6S,13aR,14aR,16aS)-6-{[(cyclopentyloxy)carbonyl]amino}-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxooctadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 3,4-dihydroisoquinoline-2(1H)-carboxylate | | Formula: | C37 H51 N5 O9 S | | Definition date: | 2013-08-07 | | Last modified: | 2020-07-20 |
|
 | | PRD_002306 | | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | | Formula: | C54 H77 N9 O12 | | Definition date: | 2019-06-04 | | Last modified: | 2019-06-04 |
|
 | | PRD_002323 | | Name: | N-METHYL-4-HYDROXY-LEUCINE CYCLOSPORIN | | Formula: | C62 H111 N11 O13 | | Definition date: | 2018-09-12 | | Last modified: | 2018-09-12 |
|
 | | PRD_002324 | | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | | Formula: | C62 H111 N11 O13 | | Definition date: | 2018-09-12 | | Last modified: | 2018-09-12 |
|
 | | PRD_001132 | | Name: | CYCLOSPORIN D | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_002251 | | Name: | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | | Formula: | C34 H50 N4 O8 | | Definition date: | 2017-01-25 | | Last modified: | 2017-05-04 |
|
 | | PRD_002240 | | Name: | 18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C30 H44 N4 O6 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002241 | | Name: | 3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | | Formula: | C30 H42 N4 O6 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002245 | | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C35 H46 N4 O7 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002246 | | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C36 H48 N4 O7 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002211 | | Name: | (2~{S})-~{N}-[(1~{R},2~{S})-1-cyano-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-3-phenyl-2-[[(~{E})-3-phenylprop-2-enoyl]amino]propanamide | | Formula: | C27 H30 N4 O4 | | Definition date: | 2015-12-09 | | Last modified: | 2015-12-09 |
|
 | | PRD_002115 | | Name: | (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-24-{(2R)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl}-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | | Formula: | C69 H125 N13 O13 | | Definition date: | 2014-11-12 | | Last modified: | 2014-11-12 |
|
 | | PRD_001162 | | Name: | Salinamide A | | Formula: | C51 H69 N7 O15 | | Description: | bicyclic depsipeptide salinamide A is a potent anti-inflammatory agent found in the marine bacterium Streptomyces sp. CNB-091. The suggested biosynthesis pathway indicates the peptide core of 1 is probably derived from the hexapeptide Thr-D-Ile-Hpg-MePhe-D-aThr-Ser (Tetrahedron Letters 39 (1998) 3915-3918). | | Definition date: | 2014-05-21 | | Last modified: | 2014-05-21 |
|
 | | PRD_001122 | | Name: | CYCLOSPORIN D | | Formula: | C64 H115 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_001123 | | Name: | CYCLOSPORIN C | | Formula: | C64 H114 N10 O14 | | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_001108 | | Name: | CYCLOSPORIN A | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 8 TO BE 4,N-DIMETHYLNORLEUCINE. | | Definition date: | 2013-06-19 | | Last modified: | 2013-06-19 |
|
 | | PRD_000868 | | Name: | N-{(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alanyl-L-alaninamid
e | | Formula: | C25 H28 Br N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
